Abstract-To observe the effects of total flavonoids of Rosa chinensis on focal cerebral ischemia reperfusion model in mice, Method: Nimodipine group, cerebral collaterals group, large, medium and small doses group of the Rosa chinensis total flavonoids were administered with corresponding drugs; Sham operation group, model group were administered the same volume of 0.5%CMC, 1 times a day, continuous administration of 7d. After 1h at 7d to medicine, the focal cerebral ischemia reperfusion model was made by thread embolism method, The blank group only exposed the left blood vessel without Plugging wire, the model mice were only embolism in the left middle cerebral artery to establish an animal model of middle cerebral artery occlusion and reperfusion (MCAO).Result: Compared with the model group, total flavonoids of Rosa chinensis can significantly reduce the loss of neurological function score, animal mortality, serum S-100 beta protein content, reduce the infarct size, the brain tissue has a protective effect. Conclusion: the total flavonoids of Rosa chinensis in each dose group have a better effect on focal cerebral ischemia reperfusion model in mice.
I. INTRODUCTION
Cerebral ischemia, also known as stroke, refers to the supply of blood flow of the brain blood vessels to reduce or total occlusion caused by brain tissue degeneration, necrosis caused by a series of symptoms or signs [1] , and the clinical manifestations of hemiplegia, slurred speech, reduce tactile and other features. Cerebral ischemia reperfusion injury (CIRI) is refers to the cerebral artery occlusion, cerebral ischemia, hypoxia and lack of energy supply, however restore blood perfusion and oxygen supply, tissue or organ damage aggravate the phenomenon [2] .Cerebral ischemia has a high incidence rate in the elderly, with high mortality, high disability rate and high recurrence rate, which brings a great burden to the society and the family [3] . 
A. Experimental Materials 1) Experimental drugs, reagents, instrument and animals: Total flavonoids in Rosa chinensis

II. METHODS
A. Modeling and Administration
112 mice of KM mice with 26-29g were divided into 7 groups and 16 mice in each group. Nimodipine group (positive control drug, the dosage of 30mg/kg, pro 0.5%CMC with the drug concentration of 3mg/ml, 0.1ml/10g, 15 times the clinical dosage); Brain capsule group (positive control drug, the dosage of 750mg/kg, pro 0.5%CMC with the drug concentration of 75mg/ml, 0.1ml/10g, 15 times the clinical dosage);Total flavonoids in Rosa chinensis large, medium and small dose group (300mg/kg, 150mg/kg, 75mg/kg, pro 0.5%CMC with 30mg/ml,, 15mg/ml, 7.5mg/ml, 0.1ml/10g); Sham operation group, model group were administered the same volume of 0.5%CMC, 1 times a day, continuous administration of 7d.After 1h at 7d to medicine, left incision in the middle of the neck of mice after anesthesia , layer by layer to Isolate and expose the left common carotid artery (CCA) and external carotid artery (ECA), internal carotid artery (ICA). Ligate the common carotid artery and the external carotid artery .Then temporarily clip internal carotid artery with arterial clamp. Besides, cut an incision of 0.2mm from 1 cm of the bifurcation of the common carotid artery. Insert a thread Line bolt with more than 8-10mm from bifurcation of common carotid artery into the internal carotid artery until there is resistance. Then blocked the entrance of the middle cerebral artery and ligate internal carotid artery (The blank group only exposed the left blood vessel without Plugging wire); finally gently pulled out the plug line after 2h. The model mice were only embolism in the left middle cerebral artery to establish an animal model of middle cerebral artery occlusion and reperfusion (MCAO).
B. Detection Index
Neurological scores after 2h: Longa criteria were used to score and Scoring criteria: 0: no neurological deficit symptoms, normal activities. 1 points can't fully extend to the contralateral forepaw; 2: crawling to hemiplegia contralateral circling; 3: when walking, body to hemiplegia side dumping them; 4: unable to walk spontaneously, consciousness loss; 5 points: death. Score 1-3 points for successful modeling, weed out unqualified rats. 0 points and 4 points removed); eyeball blood, half an hour later, centrifugal, supernatant were measured by S-100β protein content; mice were decapitated after rapid stripping brain tissue, placed in -20 degrees Celsius freezer and frozen 15min, removed the cerebellum, the rest of the olfactory bulb and the lower part of the brain stem, coronal cut four knife, cut into five pieces. Then quickly placed slices in 1%TTC liquo configured by pH=7.2 phosphate buffer, in 37 DEG C water bath, to avoid light conditions after incubation of 10min.After taking out in 10% formalin in the save 24h.After staining, the non ischemic area was rose red, and the infarct area was white. After taking pictures of digital cameras, the total area of the 10 slices of five slices and the area of the infarct area were calculated by image analysis software, and the percentage of the total area of the infarct area was obtained. Table I From the table can be seen, The sham operation group had no neurological deficits, There were various degrees of neurological dysfunction in the remaining groups after ischemia 2h;Compared with the sham operation group, the model group had significant statistical significance (P<0.01);It shows that the model is successful. Nimodipine group was significantly different (P<0.05), Which significantly improves neurological impairment; Large, medium and small doses of the Rosa chinensis total flavonoids and cerebral collaterals group have significant statistical significance, which Significantly improve the mice's nerve function injury and reduce the score of neurological deficits. Table II , Fig. 1 . From the table can be seen, compared with the sham operation group, the content of S-100β protein in the serum of model group was significantly increased (P<0.01) and the area of cerebral infarction was significantly increased (P<0.01), which showed that focal cerebral ischemia reperfusion model was successful. Compared with model group, Large, medium and small doses of the Rosa chinensis total flavonoids, Nimodipine group and cerebral collaterals group can significantly reduce the content of S-100β protein (P<0.01) and Significantly reduced infarct size in the mouse brain (p<0.01). 
III. RESULTS
A. The Effect of The Neurological Deficits Score and Mortality on Focal Cerebral Ischemia Model in Mice Was Shown in
B. The Effect of Serum S-100β protein and Cerebral Infarction Rate on Focal Cerebral Ischemia Model in Mice Was Shown in
IV. CONCLUSION
Compared with the model group, total flavonoids of Rosa chinensis can significantly reduce the loss of neurological function score, animal mortality, serum S-100 beta protein content, reduce the infarct size, the brain tissue has a protective effect. The total flavonoids of Rosa chinensis in each dose group have a better effect on focal cerebral ischemia reperfusion model in mice.
Discussion Stroke is one of the main diseases threatening human health. With the aging of the population in our country, the incidence of stroke is increasing year by year, among which the most common ischemic stroke is the most common [4] .Modern medicine thinks the cerebral ischemia reperfusion injury is a very complicated process, there are many pathophysiological mechanisms involved, including inflammation, oxidative stress and excitotoxicity and the blood-brain barrier, the mechanism of mutual cross effects ultimately lead to irreversible brain injury organization [5] .
Chinese medicine believes that qi deficiency and blood stasis is one of the main pathogenesis of ischemic stroke [6] .Modern studies suggest that after cerebral ischemia the body's blood can't flow smoothly, resulting in thrombosis, causing the expression of inflammatory molecules and inflammatory cells aggregation, making for neurotoxicity and nerve damage. Therefore, promoting blood circulation and removing blood stasis, clearing away heat and toxic materials is an important treatment for cerebral ischemic diseases in Chinese medicine. Rosa chinensis can regulate menstruation by blood circulation, subdhing swelling and detoxicating [7] .Research reported Rosa chinensis flavonoids such as quercetin in the prevention and treatment of diabetes, cardiovascular and cerebrovascular diseases have better application [8] .
The focal cerebral ischemia reperfusion model was made by thread embolism method at present [9] .It can simulate human permanent and transient focal cerebral ischemia in different states; we can accurately control the time of ischemia and reperfusion. Because the amount of estrogen has a protective effect on the brain, we used the male mouse line embolism method to build the focal cerebral ischemia reperfusion model [10] .According to the Longa score standard; the experimental animals were selected to determine the success of the model. S-100β protein is a small molecule acidic protein, when brain injury it released into the cerebrospinal fluid, through the damaged blood brain barrier into the human peripheral blood, so that the blood content increased [11] .Therefore, the level of S-100β protein in serum after cerebral ischemia / reperfusion can reflect the degree of injury and death of central nervous system, which is used to judge the degree and prognosis of brain injury [12] .
It is a new idea to treat focal cerebral ischemia by promoting blood circulation to remove blood stasis and clearing away heat and toxic drugs. The main flavonoids in Rosa chinensis have good effect of antifungal and antiviral [13] . Through the establishment of focal cerebral ischemia reperfusion model in mice, we found that Rosa chinensis total flavonoids could reduce the loss of nerve function score, animal mortality, serum S-100 beta protein content, reduce the infarct size, and have a protective effect on the brain tissue. In this study, we well explained the pharmacological effects of the Rosa chinensis total flavonoids in the treatment of focal cerebral ischemia, which provides experimental basis for broadening the research and development of Rosa chinensis and clinical practice. 
